BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Press Releases

  Zymeworks Presents New Data from Multiple Development Programs at 2025 AACR Annual Meeting

  April 25, 2025

   · 

  13 min read
• Press Releases

  Bantam Pharmaceutical Presents New Preclinical Data for BTM-3566 at the American Association for Cancer Research (AACR) Annual Meeting 2025

  April 25, 2025

   · 

  4 min read
• Press Releases

  FORE Biotherapeutics Presents New Plixorafenib Results at AACR 2025 Demonstrating Pharmacodynamic Effect in Clinical Tumor Biopsies and Decreased V600E Mutant Allele Frequency in ctDNA of 85% of Patients

  April 25, 2025

   · 

  5 min read
• Press Releases

  NextPoint Therapeutics to Showcase Pioneering Preclinical Data on NPX125, a Novel B7-H7 Targeted Antibody-Drug Conjugate (ADC) at AACR Annual Meeting 2025

  April 25, 2025

   · 

  3 min read
• Press Releases

  Ivonescimab Receives NMPA Approval for First-Line Treatment of PD-L1-Positive NSCLC, Based on Breakthrough Head to Head Phase III Trial Demonstrating Superior Efficacy Over Pembrolizumab

  April 25, 2025

   · 

  5 min read
• Press Releases

  Myriad Genetics Highlights MRD Clinical Validity Data at American Association for Cancer Research Annual Meeting

  April 25, 2025

   · 

  6 min read
• Press Releases

  City of Hope Scientists Present Leading-Edge Research at American Association for Cancer Research (AACR) Annual Meeting

  April 25, 2025

   · 

  15 min read
• Press Releases

  PROCEPT BioRobotics’ Aquablation Therapy Spotlighted at 2025 AUA Annual Meeting Along with Expert-Led Workshops

  April 25, 2025

   · 

  6 min read
• Press Releases

  Ascendis Pharma to Report First Quarter 2025 Financial Results and Provide Business Update on May 1, 2025

  April 25, 2025

   · 

  3 min read
• Press Releases

  Ensysce Biosciences, Inc. Announces Closing of Exercise of Warrants for $2.2 Million Gross Proceeds

  April 25, 2025

   · 

  4 min read